Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
Jul 27, 2026, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $570.11 million as of July 28, 2026. Its market cap has increased by 90.39% in one year.
Market Cap
570.11M
Enterprise Value
500.17M
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.50
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from 538.37M to 570.11M, an increase of 5.90%. That is a compound annual growth rate of 0.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 570.11M | 98.52% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glorywin Entertainment Group | 359.76M |
| Northwest Biotherapeutics | 289.81M |
| CytoDyn | 271.88M |
| Vaxart | 119.44M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 85.98M |
| BioStem Technologies | 71.08M |
| Nuo Therapeutics | 49.38M |